Concepedia

Publication | Open Access

Duration of etanercept treatment and reasons for discontinuation in a cohort of juvenile idiopathic arthritis patients

DOIFull Paper Access

72

Citations

24

References

2010

Year

T Southwood, HE Foster, J Davidson, Kimme L Hyrich, C. B. Cotter, Lucy R. Wedderburn, R G Hull, H Venning, Joy K Rahman, Carole Cummins
Lara D. Veeken

Abstract

In a cohort of JIA patients treated with etanercept and followed for a median of 2 years (maximum 5 years), the majority (69%) remain on the drug.

References

YearCitations

Page 1